Want to hear some scientific mumbo-jumbo that has something to do with farting? Of course you do. Check out this press release from Microbia Inc.:
"Microbia Inc. today presented preclinical data demonstrating that its novel-mechanism therapeutic candidate to treat irritable bowel syndrome effectively relieves gastrointestinal pain and promotes gastrointestinal transit, the key defining attributes of IBS. The orally delivered compound, MD-1100, is a potent superagonist of guanylate cyclase-C, a receptor found on the surface of intestinal cells."
We're sure millions will be relieved to hear that someone is working on something to relieve irritable bowel syndrome. That's why we're here, to help you, the reader.
And we apologize for the use of "farting" above. We should have said "passing gas." Or perhaps "flatulence."
We're usually much more couth.

Posted at May 19, 2004 11:10 AM